Get Adobe Flash player 

Antibiotice Iasi gains ground on cardiovascular market

22 iulie 2008

Information in English

 
Antibiotice Iasi Co. (north-east of Bucharest), one of the largest medicine producer on the local market, reported last year sales of 10 million lei (approximately 3 million euros) of cardiovascular medicines, a surge by 67% compared to the previous year, Ziarul financiar daily reads on July 18.
 
Cardiovascular segment had the best evolution in the entire company portfolio, under conditions in which anti-infectious medicine sales (in which antibiotics are included) posted a drop of 4%, amounting at 102 million lei (30.5 million euros).
 
Cardiovascular medicines market attained last year a value of 1.2 billion lei, the biggest at the level of the entire pharmaceutical industry and one of the most competitive. Antibiotice entered with products on this market in 2006. In 2007, the company turnover stood at 229.42 million lei (68.7 million euros), 17.2% higher than the previous year.

 

1 Stea2 Stele3 Stele4 Stele5 Stele (Ne-evaluat încă)
Loading ... Loading ...
Trimite prin email Trimite prin email

Comentează acest articol

*

NOTA: Va rugam sa folositi un limbaj decent in comentariile pe care le lasati. Folosirea de cuvinte obscene, atacuri la persoana autorului (autorilor) materialului, afisarea de anunturi publicitare, precum si jigniri, trivialitati, injurii se vor sanctiona prin cenzurarea partiala a comentariului, stergerea integrala sau chiar interzicerea dreptului de a posta, prin blocarea IP-ului folosit. Site-ul financiarul.ro nu raspunde pentru opiniile postate in rubrica de comentarii, responsabilitatea formularii acestora revine integral autorului comentariului.